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EDITORIAL Inhaler choice and inhalation technique: 
key factors for asthma control
Despite the availability of highly effective therapies and evidence-based guidelines,
many patients with asthma continue to suffer symptoms and exacerbations, with
considerable disruption to their daily life.1 This may reflect under-diagnosis and poor
adherence to therapy, as well as incorrect use of inhalers. For good asthma control, it is
essential to prescribe appropriate medication according to the severity of the patient’s
disease, and to ensure correct use of inhalers to facilitate effective drug delivery as well
as adherence to the prescribed treatment.2
The drug treatment regimen for the vast majority of asthmatic patients is straightforward
and is delivered as documented by national and international guidelines. The choice of drug
delivery device is less clear. Asthma guidelines currently provide little practical guidance on
selection of inhaler devices. Rather than being spoilt for choice, physicians are more
frequently confused by the ever increasing number of drug/device combinations.3 Therefore,
without a clear process to aid clinical decision-making, the choice of inhaler may be
counterproductive and can result in very little improvement in asthma control.
Evidence from the literature4 demonstrates that when used correctly there is little
difference in clinical efficacy between different device types. However, a large number of
patients are unable to use their inhalers properly, with a consequent reduction in therapeutic
benefit.5,6 It is evident that no single inhaler device can satisfy the needs of all; therefore it is
important that the most suitable inhaler is chosen for each individual patient. The most
effective inhaler for any given patient is the one that the patient can and will use effectively
on a regular basis. Patient adherence to medical advice is an important factor because, even
if a patient can use an inhaler, we cannot assume that it will be used as prescribed.
Successful control of asthma relies heavily on patients' adherence to their prescribed inhaled
therapies; it has been estimated that adherence rates for inhaler use are between 20% and
73%,7 and a lack of adherence is associated with an increase in asthma-related adverse
effects.8
In this issue of the Primary Care Respiratory Journal, the excellent review by Chrystyn and
Price9 addresses problems associated with the use of pressurised metered-dose inhalers
(pMDIs) and dry powder inhalers (DPIs), and summarises the use of each device by pointing
out the positive and negative aspects of each. They also indicate factors to consider when
prescribing an inhalation device, and, finally, describe the advantages of the newer
hydrofluoroalkane-driven pMDIs which deliver ultrafine particles (unlike traditional pMDIs).
However, little recognition has been given to the substantial role of nurses and pharmacists
in either selecting appropriate inhaler devices for patients or in teaching and assessing
inhaler technique. Trained asthma nurses fulfil a central role in education and in teaching
patients about inhaler devices and encouraging adherence.10 Furthermore, community-
based pharmacists can play a huge role not only in demonstrating the correct use of each
type of inhaler they dispense to a patient, but also in identifying poorly controlled asthma
by scanning the use of, and dispensing patterns of, bronchodilators versus inhaled steroids.11
To facilitate educational programs the pharmaceutical industry should provide placebos for
each type of inhaler it produces to every dispensing pharmacist and prescribing clinician, as
well as to any member of the health care team, upon request, free of charge.
Chrystyn and Price9 stress the importance of regular patient education, but they do not
address the need to update healthcare professionals' skills, knowledge and competence
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regularly. Many health professionals are limited in their ability to use
inhaler devices properly12 and as a result they are not best placed to
teach patients. There is a need to ensure that they are competent
themselves to teach others.
Until now, there has been little clear comprehensive guidance to
assist clinicians in the process of inhaler selection for their patients.
General principles of inhaler selection and use have been reviewed
in detail with a list of eight points to consider.4 An algorithm
incorporating the patient’s inspiratory flow and ability to coordinate
pMDI actuation with inspiration has been also proposed.13 More
recently, the Aerosol Drug Management Improvement Team
(ADMIT), a consortium of European respiratory physicians with a
common interest in promoting excellent delivery of inhaled drugs,
proposed a practical algorithm to facilitate patients’ instruction on
optimal inhaler use.14 At each consultation, the physician should
establish the patient's current level of asthma control: if the disease
has been well controlled for >3 months, therapy should be stepped
down gradually according to guidelines; conversely, if the patient is
poorly controlled, adherence to medical advice and (most
importantly) inhalation technique should be assessed. If the patient
is unable to use a particular inhaler correctly despite repeated
attempts after instruction, an alternative inhaler should be
considered. In cases where ongoing uncontrolled asthma persists
despite correct inhaler technique, asthma therapy should be
stepped up according to guidelines. Although there is no evidence
that patients’ compliance is improved by changing to a different
inhaler, it is likely that this strategy will be cost effective since it could
facilitate control of asthma without increasing drug dosage or
adding other agents.
We now need effectiveness studies, especially in the real world,
to see whether this approach is applicable to the treatment of
asthma patients in the community. We believe that choosing a
method of drug administration in patients with obstructive airways
diseases is as critical as the choice of medication itself, and that in
future the choice of a new compound will be secondary to the need
to choose the appropriate inhaler device.
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